Financials

  • Market Capitalization 23.82 M
  • Employee 11
  • Founded 1996
  • CEO N/A
  • Website www.cellectar.com
  • Headquarter Delaware, United States
  • FIGI BBG000G9WFQ5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.35
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4508
GNTA
Genenta Science S.p.A. - American Depositary Shares
1.05 USD+6.06%-17.32%-33.54%-72.15%24.60 M USD
4511
TVRD
Tvardi Therapeutics, Inc. - Common Stock
1.81 USD0.00%-2.16%-26.42%-49.72%24.14 M USD
4516
MRKR
Marker Therapeutics, Inc. - Common Stock
1.42 USD-2.74%+1.43%+19.33%+44.90%23.68 M USD
4530
KZIA
Kazia Therapeutics Limited - American Depositary Shares
14.06 USD-16.80%+3.69%+11.76%+140.34%22.76 M USD

Notizie